Welcome to our dedicated page for United States Antimony SEC filings (Ticker: UAMY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Antimony tonnage tables, reclamation liabilities, fluctuating smelter yields—United States Antimony’s SEC documents can overwhelm even experienced analysts. Whether you are searching for “United States Antimony SEC filings explained simply” or need the latest “United States Antimony insider trading Form 4 transactions”, the raw EDGAR feed alone rarely answers core valuation questions.
Stock Titan solves this problem with an AI layer built for complex resource companies. Our system scans every 10-K, 10-Q, 8-K and proxy in real time, then delivers plain-English summaries alongside the original text. You’ll see environmental footnotes, mine-life assumptions and segment revenue called out automatically. Need to monitor Form 4 activity? We provide “United States Antimony Form 4 insider transactions real-time” alerts so you learn when executives buy or sell before the market digests the move. Looking for production trends? Our dashboards link the “United States Antimony quarterly earnings report 10-Q filing” to historical ore grades and cash-cost metrics.
Here’s what becomes effortless:
- Compare year-over-year mine output using data extracted from the annual report 10-K simplified
- Track executive stock transactions Form 4 against antimony price swings
- Review proxy statement executive compensation details next to production bonuses
- Decode 8-K material events explained—from furnace shutdowns to offtake agreements
With comprehensive coverage and instant AI commentary, Stock Titan turns hundreds of pages into decisive insight. Stop skimming PDFs and start understanding United States Antimony SEC documents with AI in minutes.
John M. Keane, a director of United States Antimony Corp (UAMY), filed an Initial Statement of Beneficial Ownership reporting no currently owned common shares and two time‑based awards granted on
United States Antimony Corp (UAMY) director and officer Lloyd Bardswich reported a sale of 40,000 shares of the company's common stock on 09/29/2025 at a price of $6.44 per share. After the sale the filing shows beneficial ownership listed as 594.047 (as reported). The Form 4 was signed by the reporting person on 10/04/2025. No derivative transactions or additional purchases were disclosed.
Jeffrey Russell Fink, an officer and director of United States Antimony Corp (UAMY), reported two open-market dispositions on 10/03/2025. The filing shows a sale of 2,833 shares at $8.16 and a sale of 8,000 shares at $8.12. After those transactions the reported beneficial ownership totals are listed as 64,000 shares and 56,000, respectively, held in a direct capacity. The Form 4 is signed by the reporting person and indicates the transactions were not reported as part of a 10b5-1 plan. The filing provides a straightforward record of insider selling activity without additional commentary or explanatory notes.
United States Antimony Corp (UAMY) director Michael A. McManus Jr. reported selling 50,000 shares of common stock on 10/01/2025 at a reported price of $7.316 per share. After the sale he beneficially owns 531,965 shares. The Form 4 was signed on 10/02/2025 and shows the transaction as a direct disposition by a director.
United States Antimony Corp (UAMY) filed a Form 144 disclosing a proposed sale of 50,000 common shares with an aggregate market value of $350,000. The filing states the shares represent part of the company's outstanding 120,723,320 shares and that the approximate sale date is 10/01/2025 through the NYSE via Merrill Lynch. The shares were acquired on 05/15/2024 as a stock bonus from US Antimony Corp, and no sales by the same person were reported in the past three months. The filer certifies they are unaware of any undisclosed material adverse information about the issuer.
United States Antimony Corp (UAMY) filed a Form 144 reporting a proposed sale of 12,500 common shares through Merrill EDGE (Jacksonville, FL) on the NYSE American with an approximate aggregate market value of $98,375. The shares were acquired on 01/29/2025 as restricted stock vesting from the issuer, totaling 33,333 shares received on that date and paid as compensation. The filer reports 120,723,320 shares outstanding and lists an approximate sale date of 09/24/2025. The filing states there were no securities sold in the past three months by the selling person and includes the standard representation that the seller is not aware of undisclosed material adverse information.
Form 144 filed for United States Antimony Corp (UAMY) reporting a proposed sale of 40,000 common shares with an aggregate market value of $245,000, listed for an approximate sale date of 09/29/2025 on NYSE American through broker Canaccord Genuity.
The filing shows the shares were originally acquired in open-market cash purchases on 08/18/2022 and 08/19/2022 in four lots totaling the 40,000 shares, with payment settled in cash. The issuer has 120,723,320 shares outstanding. The filer reports no sales of these securities in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
FAQ
What is the current stock price of United States Antimony (UAMY)?
What is the market cap of United States Antimony (UAMY)?
